The in vivo results showed that Nec-1 and cholesterol-conjugated si-RIPK1 significantly reduced the extent of pancreatic tissue necrosis, inhibited the massive release of inflammatory mediators and oxidative stress damage, and ultimately effectively decreased the severity of AP. This evidence concerns the gene RIPK1 and alkaline phosphatase measurement.